Recherche
Résultats 1-6 de 6
-
Real-world effectiveness of pembrolizumab in advanced melanoma: analysis of a French national clinicobiological database
Immunotherapy, Future Medicine, 02-06-2021, 13; 11, 905-916Compte-rendu et recension critique d'ouvragetexte intégral -
Management of adjuvant settings for Stage III melanoma patients in France prior to checkpoint inhibitors: epidemiological data from the RIC-Mel database
EUROPEAN JOURNAL OF DERMATOLOGY, John Libbey Eurotext, 08-2020, 30; 4, 389-396Compte-rendu et recension critique d'ouvrage -
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France
Current Oncology, MDPI, 2022, 29; 12, 9255-9270Compte-rendu et recension critique d'ouvragetexte intégral -
Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort
Journal of the American Academy of Dermatology, Elsevier, 04-2023, 88; 4, 808-815Compte-rendu et recension critique d'ouvrage -
Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study
Cancers, MDPI, 2020, 12; 6, 1666Compte-rendu et recension critique d'ouvragetexte intégral -
Quality-of-life assessment in French patients with metastatic melanoma in real life
Cancer, Wiley, 2020, 126; 3, 611-618Compte-rendu et recension critique d'ouvrage